InsidersTradesSigma
젬백스 Stock: price and insider trades · South Korea · DART (FSS)
Track the 젬백스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 젬백스 has logged 138 insider filings. Market capitalisation: €488.3bn. The latest transaction was reported on 19 June 2026 (Other). Among the most active insiders: 젬앤컴퍼니. Every trade is free.
138
Insider Decl.
0
Thresholds
€3m
69 ops.
Buy Volume
€2m
14 ops.
Sell Volume
19Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,058 of 26,212 companies
33.4
score / 100
Value31
Quality36
FCF yld-0.2%
Earn yld-2.3%
EV/EBITDA·
ROE·
Gross mgn43%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 19 June 2026
Declarations138 total
25 of 138 declarations
About 젬백스
Gemvax is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.